BusinessLyfebulb and UnitedHealth Group Announce an Innovation Challenge for Patient Entrepreneurs with Inflammatory Bowel DiseaseBy Nasdaq OMXApr 23, 2018, 7:18 PM UTC
BusinessRegentys, Cook Biotech to Collaborate in Developing, Delivering Unique Ulcerative Colitis TreatmentBy Nasdaq OMXFeb 14, 2018, 12:00 PM UTC
BusinessVitality Biopharma Submits Orphan Drug Designation Request to FDA for Flagship THC Prodrug VITA-100By Nasdaq OMXJan 17, 2018, 1:01 PM UTC
BusinessVitality Biopharma Introduces Cannabinoid Pharmaceutical VITA-100 as Prodrug of THCBy Nasdaq OMXJan 3, 2018, 1:31 PM UTC
BusinessAtlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative ColitisBy Nasdaq OMXMay 30, 2017, 12:28 PM UTC
BusinessAtlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative ColitisBy Nasdaq OMXMay 30, 2017, 12:27 PM UTC
BusinessAtlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative ColitisBy Nasdaq OMXMay 30, 2017, 12:27 PM UTC
BusinessAtlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative ColitisBy Nasdaq OMXMay 30, 2017, 12:27 PM UTC
